Why is the market design for innovative pharmaceuticals not well understood?
Saved in:
| Title: | Why is the market design for innovative pharmaceuticals not well understood? |
|---|---|
| Authors: | Olivença F; Lane Clark & Peacock LLP, London, W1U 1DQ, UK., Diaz J; Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK., Ramagopalan SV; Lane Clark & Peacock LLP, London, W1U 1DQ, UK.; Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK., Garrison LP Jr; The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA. |
| Source: | Journal of comparative effectiveness research [J Comp Eff Res] 2024 Oct; Vol. 13 (10), pp. e240105. Date of Electronic Publication: 2024 Sep 10. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: Becaris Publishing Country of Publication: England NLM ID: 101577308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6313 (Electronic) Linking ISSN: 20426305 NLM ISO Abbreviation: J Comp Eff Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
